STEAP2 and glioblastoma: As shown in Figure 5C, high STEAP2 expression was associated with poor OS for cancers of THCA (p = 0.00063) but with favorable progression for GBM + LGG (p = 0.0026), KIRC (p = 0.0002), and SKCM (p = 0.02).